investorscraft@gmail.com

Intrinsic ValueTerilogy Holdings Corporation (5133.T)

Previous Close¥323.00
Intrinsic Value
Upside potential
Previous Close
¥323.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Terilogy Holdings Corporation operates in the IT services sector, specializing in IP-network-related and network security solutions for corporate clients in Japan and internationally. The company generates revenue through a diversified model, including hardware and software sales, system consulting, network construction, and maintenance services. Its product portfolio spans routers, switches, WLAN equipment, and advanced security solutions like firewalls and intrusion detection systems, catering primarily to manufacturers and telecommunications carriers. Terilogy distinguishes itself with proprietary offerings such as CloudTriage, a cloud-based performance monitoring service, and EzAvater, a robotic process automation tool, positioning it as a niche player in network infrastructure and cybersecurity. The firm’s focus on SMEs through managed-VPN, web conferencing, and rental server solutions further diversifies its market reach. With a legacy dating back to 1989, Terilogy has established credibility in Japan’s competitive IT services landscape, though its international presence remains limited. The company’s hybrid approach—combining product sales with high-margin services—strengthens its resilience against pure hardware commoditization.

Revenue Profitability And Efficiency

In FY2024, Terilogy reported revenue of ¥6.88 billion, with net income of ¥188.7 million, reflecting a modest net margin of 2.7%. Operating cash flow stood at ¥324.1 million, though capital expenditures of ¥-153 million indicate ongoing investments in infrastructure. The diluted EPS of ¥11.51 suggests efficient capital allocation relative to its market cap, but profitability metrics remain subdued compared to sector peers.

Earnings Power And Capital Efficiency

The company’s earnings power is underpinned by recurring service revenue, including maintenance and cloud-based solutions, which likely contribute to stable cash flows. However, its ROIC (Return on Invested Capital) is not disclosed, and the modest net income implies room for improvement in capital efficiency. The low beta of 0.343 suggests earnings are less volatile than the broader market.

Balance Sheet And Financial Health

Terilogy maintains a robust balance sheet with ¥1.96 billion in cash and equivalents against total debt of ¥369 million, indicating a strong liquidity position. The negligible leverage and high cash reserves provide flexibility for strategic investments or weathering downturns, though the lack of detailed asset breakdowns limits deeper analysis.

Growth Trends And Dividend Policy

Growth appears tepid, with revenue and net income figures suggesting limited recent expansion. The dividend payout of ¥5 per share, while modest, signals a commitment to shareholder returns, though yield calculations are unavailable. The absence of explicit growth catalysts in the data warrants caution.

Valuation And Market Expectations

At a market cap of ¥6.49 billion, Terilogy trades at approximately 0.94x revenue and 34.4x net income, reflecting modest expectations. The low beta implies the market perceives it as a defensive play, but valuation multiples lack context without peer comparisons.

Strategic Advantages And Outlook

Terilogy’s niche expertise in network security and hybrid service-product offerings provide competitive insulation. However, its reliance on the Japanese market and limited scale pose challenges. The outlook hinges on expanding high-margin services and leveraging CloudTriage’s potential, though macroeconomic pressures in IT spending could constrain near-term growth.

Sources

Company description, financial data from disclosed filings, and market metrics from exchange sources.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount